HIV/AIDS vaccine (Biological Mimetics/GlaxoSmithKline)

N/A

Report date: 2025/03/20 15:42:34

Base Information

Drug NameHIV/AIDS vaccine (Biological Mimetics/GlaxoSmithKline)
Drug Alias NameN/A
ClassificationVaccines
Mechanisms of ActionHIV envelope protein gp120 modulatorsTransmembrane glycoprotein gp41 modulators
TargetsHIV envelope protein gp120Transmembrane glycoprotein gp41
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiological Mimetics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiological MimeticsGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A